Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rigshospitalet, Denmark | OTHER |
| Technical University of Denmark | OTHER |
| Emergency Medical Services, Capital Region, Denmark | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The study aims to investigate the use of wireless, continuous monitoring in patients at home including the frequency of alarms triggered by abnormal vital parameters and their significance for (re)hospitalisation/Serious Adverse Events(SAE) and/or death within 30 days.
Acute hospital admissions challenge the capacity of the healthcare system. Readmission is common among patients with chronic medical diseases, and many patients admitted for acute conditions are often subsequently observed at the hospital for hours and often with one overnight stay for observation purposes alone. Recent medico technical research has allowed continuous and wireless monitoring of patients' vital signs in-hospital, but the practice at home remains uninvestigated. However, the technology has the potential to relieve hospital overcrowding by offering continuous and real time analytics of vital signs in high-risk patients at home.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Continuously monitoring | Device | Included patients are monitored with WARD equipment the first days after discharge. Monitoring will last for a maximum of three days. |
| Measure | Description | Time Frame |
|---|---|---|
| (Re)admission | Defined as acute admission to hospital for at least 12 hours with relation to prior discharge or EMS contact | within 30 days |
| Serious Adverse Events | Any adverse event, including acute admissions during the observational period. Criteria defined in protocol. Adverse events will be manually categorised as a 'severe adverse event' (SAE), or simple 'adverse event' (AE). | within 30 days |
| Mortality | within 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| (Re)admission | Defined as acute admission to hospital for at least 12 hours with relation to prior discharge or EMS contact | within 7 days after discharge/assessment by paramedic personnel |
| Inquiries to the Emergency Medical Service |
| Measure | Description | Time Frame |
|---|---|---|
| Frequency of automatically generated alerts on deviating vital signs | per device per patient per day | 72 hours |
| Number of automatically generated alerts | From all devices worn, per patient per day |
Inclusion Criteria:
Adult patients (≥18 years) admitted (with at least one night stay) with an acute medical disease and scheduled for discharge to their own homes
Adult patients (≥18 years) who have contacted the EMS and, after assessment by paramedic personnel, not deemed sick enough for immediate hospital admission.
Exclusion Criteria:
Patients placed on palliative treatment.
Acceptable chronically abnormal vital parameters of SpO2<88%, MAP<70, RR>24, or HR>110.
Allergy to plaster, plastic, or silicone.
A pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
If the patient was deemed not able to open the front door when visited by the investigator.
Inability to give informed consent.
Not provided
Not provided
Not provided
Patients admitted with an acute medical disease at Bispebjerg Hospital or Rigshospitalet, or assessed by paramedic personnel at home after contact to the EMS.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Emilie Sigvardt, MD | Bispebjerg Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bispebjerg Hospital | Copenhagen | NV | 2400 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000075902 | Clinical Deterioration |
| ID | Term |
|---|---|
| D018450 | Disease Progression |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Defined as patients calls to 1813/112
| within 30 days |
| Mortality and types of SAEs | Any adverse event, including acute admissions during the observational period. Criteria defined in protocol. Adverse events will be manually categorised as a 'severe adverse event' (SAE), or simple 'adverse event' (AE). | within 30 days |
| 72 hours |
| Frequency of alerts which are responded to by healthcare personnel | Number of alerts triggered by deviating vital signs, per patient per day | 72 hours |
| Fraction of time within the study period with at least one type of data transmitted in real time from patients' homes. | 72 hours |